The association between drugs and criminal behaviour has been known for millennia, alcohol and cannabis in particular having been recognized as agents which can produce aggression and violence. In recent years an increasing number of defendants have claimed in mitigation that they commited a criminal act while under the influence of drugs. Drugs may not only be of importance as a factor in criminal action, however, but may also be involved in apparent admissions of guilt, and in apparent consent to action. Clinical pharmacologists and psychopharmacologists have been called upon as expert witnesses in such cases, and also where the results of drug analysis, both qualitative and quantitative, have provided important evidence for prosecution or defence.
Drug-related crime Drug addiction
The relationship between drug addiction and crime is complex and beyond the scope of this paper, but has recently been extensively reviewed'. Drugs of addiction, -such as narcotics, cocaine and amphetamines, may on the one handprecipitate -aggressive behaviour, while on the other the addict may resort to viola"itA +r% e%hk+o; rne%finAm xx;+lk oxh;S 1 Mandrax, now withdrawn from most markets, was a combination of methaqualone and diphenhydramine, both marked central nervous depressant drugs.
A 50-year-old man was charged with arson, having drenched his daughter's bed and set light to it while she was still in it.
His defence was that on the day Qfthe offence he.hadtaken 2 Mandrax tablets in the morning followed by 4 Amitriptyline has been invo which I have given evidence: Lehast oneen taken drs The pharmacological basis of such-rare paradoxileast one of the drugs cal aggressive reactions associated with drugs generally found to be useful in reducing violent behaviour 1 factor in aggressive is obscure. There is some evidence that agents which reduce brain 5-hydroxytryptamine (5HT) activity lved in several cases in may increase agression2, and it is of interest that both amitriptyline and propranolol interact with 5HT systems. sd with attempted murder systems5.
In defenc he claA confounding factor which must always be con-In defence he claimecl to-sidered when thereis a hi8tory of injection of an triptylineafter drinking 4 a itry o neto fa re the incident. Following hallucinogen, narcotic or other-centrally acting drug the prosecution dropped before an alleged criminal act is the possibility of [ accepted a plea of guilty underlying psychotic disease. A 24-year-old man, rensive *eapon.:
charged with assault and intent to do grievous bodily d writh murder of a nightharm to -a young woman, claimed that this followed lzied attack in which he experimentation with several drugs including LSD I impaled him to the floor and narcotics, but clinical examination suggested igled the guard's Alsatian that he was schizophrenic and this was cotifirmed by fence was that some 8-10 specialist opinion.
Dangerous driving
Although a claim of having taken one or more drugs for therapeutic purposes is sometimes made in attempted mitigation of driving offences, the law relating to such offences is clear and the claim seldom succeeds. It is, however, a matter for considerable concern that some doctors still seem to be unaware of the potentially serious effects that centrally acting drugs can have upon driving:
A 28-year-old male lorry driver was involved in two road accidents within 6 days, both occurring about 4 hours after taking 20mg diazepam; this had been prescribed by his general practitioner, who assured him on specific questioning that it would not influence his driving. Although the court was prepared to be lenient for the first accident, he was convicted of dangerous driving in the second accident, his licence withdrawn and livelihood lost, despite an appeal to the Home Secretary.
Herxheimer6 has described a case of a patient given oxazepam without warning by his doctor or by labelling of the tablets about their possible side effects: a case of careless driving was accepted as proved, but in view of the circumstances the magistrate granted the defendant an absolute discharge. Such cases illustrate the importance of warning labels for dispensed drugs in order to ensure that patients are made aware oftheir effects on driving and other skills even if the prescribing doctor fails to give adequate warning7. Herxheimer6 suggests that in cases such as these the patient would seem entitled to recover damages from the doctor. Considerable ingenuity is used in attempts to avoid such convictions, usually unsuccessfully.
A 36-year-old man was charged with dangerous driving which had resulted in the death of his passenger. Evidence was produced that his blood alcohol level following the offence was in excess of 250 mg/100 ml. His unsuccessful defence was that he was being treated with lithium carbonate for a psychiatric disorder, which had produced 'terrible thirst' and caused him to drink '2 bottles of lager'.
Shoplifting
Although unacceptable claims of diminished responsibility because of drug ingestion are sometimes made in defence against charges of shoplifting, such mitigating claims may sometimes be reasonable and have a sound psychopharmacological basis. Recent ingestion of benzodiazepines has been the basis of several claims of amnesia, so that memory about the removal of goods without payment has been lost. Delirium, a toxic confused state, may also be produced by centrally acting drugs taken therapeutically, particularly ifused in combination8.
A 55-year-old man who had been under psychiatric treatment for 10 years with amitriptyline and diazepam, was charged with shoplifting. On the day of the alleged offence he had taken four Contac capsules over 5 hours for severe nasal congestion, before going shopping. After the offence he was noted by the store detective and others to be confused, sedated and to have marked pupillary dilatation. At that time, each Contac capsule contained phenylpropanolamine 50mg and belladonna alkaloids (hyoscyamine sulphate) 250 [ig in a sustained-release formulation, the manufacturer's dose recommendation being one every 12 hours. In defence, it was claimed that amitriptyline, diazepam and hyoscyamine had summated to produce marked central nervous depression, and that amitriptyline and hyoscyamine had summated to produce an anticholinergically mediated state of delirium enhanced by the sympathomimetic affects of phenylpropanolamine, as indicated by the marked mydriasis noted in a brightly lit room. He was unconditionally discharged. Herxheimer and Haffner9 have described another case in which the prosecution did not proceed with a woman charged with shoplifting, who was being treated with the potentially sedative drugs tripolidine, salicylamide and diflunisal.
Corticosteroids can produce psychotic effects8 which have been involved in mitigating claims, not necessarily with success.
A 45-year-old man charged with shoplifting gave a 2-year history ofsevere ulcerative colitis requiring treatment with prednisolone 30-60 mg daily. When examined shortly after the alleged offence he was found to be markedly hypomanic without any remorse or evidence of feelings of guilt. His hypomania was clearly demonstrated in a vivid and even amusing way in court where his flow of words, and realistic unexpurgated description of the problems associated with uncontrolled colitis, enlivened the usually sombre and serious atmosphere, and introduced language not often heard within its walls. Nevertheless, despite the convincing and, I believe, genuine demonstration of a steroid-induced psychotic state, his conviction was upheld by the jury and he was fined.
Drugs and evidence Admission ofguilt
Defence claims are sometimes made that a statement of confession of guilt was made by the accused under duress, and it has also been claimed that earlier ingestion of drugs and/or alcohol has reduced the ability of the accused to withstand such duress.
A 44-year-old man, charged with assault involving buggery with a minor, the daughter of his mistress, claimed in defence that he had signed his confession in the late evening in the police station, one hour after having taken two Mandrax tablets and half a pint of beer in his home before the unexpected arrival of police officers. In further evidence he stated that he had been intimidated by the police, and because of the profound sedation and desire to sleep produced by the Mandrax and alcohol, as well as fear, had signed a confession already prepared by the police. He was found not guilty by the jury.
Consent
A 45-year-old woman was principal witness in an alleged case of rape. She claimed that she had not consented to sexual intercourse with the accused in his flat, to which she had voluntarily accompanied him. Her medical history included (a) epilepsy, for which she was being treated with phenytoin and phenobarbitone; (b) hypertension, treated with methyldopa and bendrofluazide, and (c) alcoholism, for which she had received several convictions for drunken behaviour. On the evening ofthe alleged offence, she admitted to having drunk brandy and several pints of beer in a public house before going home with the accused. Among several issues which she sought to raise in defence of her claim of rape were that she was not able to give consent to intercourse because she was not in full control of her faculties at the time, and that she had no recollection of giving consent. This case raises wider issues of consent while under the influence of centrally acting drugs. For example, to what extent are patients treated with them able to give valid consent to participate in clinical research procedures? Drug analysis and pharmacokinetics Identification: Toxicologists and clinical pharmacologists are frequently involved in discussions of evidence on the presence of drugs or their metabolites in body fluids, and the significance of the concentrations found in respect of the crime under investigation. The importance of such evidence is increasing as the database on concentration/effect relationships of drugs in man increases. This is an important aspect of the work of clinical toxicology units and their collaboration in analysing, collating and disseminating such information.
Pharmacokinetics and 'back-tracking'. An important consequence of the growth of the science of pharmacokinetics is the ability to predict, for many drugs, the range of plasma, body fluid, or tissue drug or metabolite concentrations following their administration by mouth or other routes. This means that the determination of such a concentration at a known time interval after ingestion or parenteral administration permits extrapolation to the range of dose or amount taken, within certain confidence limits.
There has been some controversy following conviction for a driving offence under the influence of alcohol, when the blood alcohol concentration was calculated to be above the legally-permitted limit on the basis of extrapolation backwards, 'backtracking', from a determination made some time later. This is a complex matter, and may involve other issues including the relationship between breath and blood alcohol concentrations. Nevertheless, relationships exist between simultaneous tissue and blood concentrations, and between such concentrations over time, and these can be experimentally determined within certain probability limits. As this field ofscientific enquiry increases, and as analytical techniques become more sensitive and accurate, and computer modelling is shown realistically to reflect in vivo events, there is no reason why such evidence should not be presented, together with an estimate of its statistical probability limits, as part of a prosecution or defence case to a jury.
Conclusions
As awareness increases of the influence of drugs of different pharmacological classes on human behaviour, so will their possible role in the aetiology of criminal actions be claimed in mitigation by the accused and defence lawyers. Their influence on statements by the accused and witnesses, and on consent to action by others involved in alleged criminal activity, will also be increasingly implicated. With better analytical techniques, kinetic as well as pharmacodynamic aspects of drug action will also be included more often in evidence. These are important areas of activity for those with training in clinical pharmacology and clinical psychopharmacology.
